Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-01-18 to 2022-01-19
Current total value of award: $1339.17
Description: 4555996601!ORALAIR 300 IR SUBLINGUAL TAB 30S